ESCRS - FP09.03 - Visual Outcomes After Implantation Of A Segmental Refractive Multifocal Intraocular Lens

Visual Outcomes After Implantation Of A Segmental Refractive Multifocal Intraocular Lens

Published 2024 - 42nd Congress of the ESCRS

Reference: FP09.03 | Type: Free paper | DOI: 10.82333/1a97-za53

Authors: Myriam Susanne Böhm* 1 , Eva Hemkeppler 1 , Klemens P. Kaiser 1 , Marvin L. Biller 1 , Petra Davidova 1 , Zubeida H. Omerovic 1 , Jakob Wend 1 , Annika Klinkenbusch 1 , Thomas Kohnen 1

1Ophthalmology,Goethe University ,Frankfurt,Germany

Purpose

To evaluate outcomes on visual acuity at different distances, range of vision, patient satisfaction, spectacle independence, visual quality and refractive outcomes in cataract patients implanted with the multifocal Acunex VarioMax IOL.

Setting

Department of Ophthalmology, Goethe University, Frankfurt, 

Methods

In this prospective, single-site, clinical trial patients after bilateral implantation of the Acunex Variomax IOL were included. After 3-months follow-up, binocular uncorrected and corrected visual acuities at distance (UCDVA, BCDVA), intermediate (UCIVA, DCIVA) and near (UCNVA, DCNVA) will be measured. Spectacle independence, defocus curve ranging from -5.0 D to +2.0 D in 0.5D steps, patient satisfaction and visual disturbances will be also evaluated.

Results

We enrolled 17 patients with an average age of 64.3 ± 10.33 years in the clinical trial. Three months postoperative monocular DCVA, DCIVA in 80cm was >0.1logMAR and DCNVA in 40cm was 0.2logMAR. Binocular DCVA and DCIVA in 80cm was >0.1logMAR and DCNVA in 40cm was 0.2logMAR. Defocus curve shows two peaks at 0D (-0,08logMAR) and 2D (0.08logMAR). Contrast sensitivity was 1.46 ± 0.19logCS under photopic conditions and 1.27 ± 0.32 logCS under mesopic conditions. 14% of patients need spectacles for intermediate or near vision. 43% of the included patients reported halos at night but were not disturbed of them.

Conclusions

Visual performance of the Acunex VarioMax IOL showed good VA at all distances, high patient satisfaction and spectacle independence with good contrast sensitivity 3 months postoperatively.